PubRank

Michael Cohen-Wolkowiez

Author PubWeight™ 42.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Innovative clinical trial design for pediatric therapeutics. Expert Rev Clin Pharmacol 2011 1.64
2 Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012 1.63
3 No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. Pediatr Infect Dis J 2015 1.53
4 Antifungal therapy and outcomes in infants with invasive Candida infections. Pediatr Infect Dis J 2012 1.53
5 Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections. Pediatr Infect Dis J 2011 1.30
6 Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2011 1.19
7 Fluconazole loading dose pharmacokinetics and safety in infants. Pediatr Infect Dis J 2011 1.14
8 Pediatric cardiovascular drug trials, lessons learned. J Cardiovasc Pharmacol 2011 1.13
9 Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J 2012 1.07
10 Population pharmacokinetics of micafungin in neonates and young infants. Antimicrob Agents Chemother 2010 1.06
11 Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants. Pediatr Infect Dis J 2013 1.02
12 Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children. Pediatr Infect Dis J 2012 0.90
13 Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach. Antimicrob Agents Chemother 2011 0.87
14 Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery. Pediatr Crit Care Med 2013 0.86
15 Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis. Pediatr Infect Dis J 2013 0.86
16 Population pharmacokinetics of intravenous acyclovir in preterm and term infants. Pediatr Infect Dis J 2014 0.85
17 Pharmacokinetics of antifungal agents in children. Early Hum Dev 2011 0.85
18 Sildenafil exposure and hemodynamic effect after Fontan surgery. Pediatr Crit Care Med 2014 0.85
19 Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective. Br J Clin Pharmacol 2013 0.84
20 Late-onset bloodstream infections in hospitalized term infants. Pediatr Infect Dis J 2014 0.84
21 Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation. J Cardiovasc Pharmacol 2011 0.83
22 Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation. Pediatr Infect Dis J 2012 0.83
23 The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos 2013 0.82
24 Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections. Pediatr Infect Dis J 2014 0.82
25 Pharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults. Expert Rev Clin Pharmacol 2014 0.81
26 Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis. Pediatr Infect Dis J 2012 0.80
27 Lessons learned in pediatric clinical research to evaluate safe and effective use of drugs in pregnancy. Obstet Gynecol 2015 0.79
28 Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole. Curr Drug Metab 2013 0.79
29 Risk factors for invasive candidiasis in infants >1500 g birth weight. Pediatr Infect Dis J 2013 0.79
30 Very late onset infections in the neonatal intensive care unit. Early Hum Dev 2011 0.79
31 Recent Advances in the Detection of Neonatal Candidiasis. Curr Fungal Infect Rep 2010 0.78
32 Evidence-based guidelines for pediatric clinical trials: focus on StaR Child Health. Expert Rev Clin Pharmacol 2012 0.78
33 Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation. Pediatr Infect Dis J 2016 0.77
34 Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications. Drugs 2014 0.77
35 Echinocandins for the nursery: an update. Curr Drug Metab 2013 0.77
36 Pharmacokinetic studies in infants using minimal-risk study designs. Curr Clin Pharmacol 2014 0.77
37 Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis. J Clin Pharmacol 2014 0.76
38 Outcomes of catheter-associated infections in pediatric patients with short bowel syndrome. J Pediatr Gastroenterol Nutr 2010 0.76
39 Advances in the treatment of invasive neonatal candidiasis. Expert Opin Pharmacother 2015 0.76
40 Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine. Ther Drug Monit 2016 0.75
41 Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients. Ther Drug Monit 2016 0.75
42 A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation. Ther Drug Monit 2017 0.75
43 Commentary: pediatric antifungal drug development: lessons learned and recommendations for the future. Pediatr Infect Dis J 2012 0.75
44 Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach. Clin Neuropharmacol 2016 0.75
45 Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J 2017 0.75
46 Predictors of positive cerebrospinal fluid cultures in infants with bacteremia. Pediatr Infect Dis J 2014 0.75
47 Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia. Ther Drug Monit 2014 0.75
48 Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in Infants. Pediatr Infect Dis J 2017 0.75
49 Enhanced culture detection of Citrobacter koseri from cerebrospinal fluid in BacTec. Pediatr Infect Dis J 2005 0.75